Eli Lilly hasnt yet announced the brand name or price for orforglipron, and costs will only be confirmed after FDA approval
References Ristaino JB, Anderson PK, Bebber DP, Brauman KA, Cunniffe NJ, Fedoroff NV, Finegold C, Garrett KA, Gilligan CA, Jones CM, Martin MD, MacDonald GK, Neenan P, Records A, Schmale DG, Tateosian L, Wei Q
Were excited to release our new peptide mixing guide: A free, research-informed resource developed by our clinical team, designed to help you safely combine compatible peptides in a single syringe
This systematic review of low-to-moderate evidence on the GLP-1 user risk of perioperative regurgitation and aspiration will examine the ongoing challenges in developing evidence-based clinical guidelines for patients using GLP-1 RAs, particularly with respect to perioperative management